Profile
Dr. Hans Peter Bøhn is a Chairman at PCI Biotech Holding ASA and a Manager at Svanhild og Arne Musts fond for medisinsk forskning.
He is on the Board of Directors at Zelluna Immunotherapy AS and SpinChip Diagnostics AS.
Dr. Bøhn was previously employed as an Independent Analyst by Fondsfinans AS.
Hans Peter Bøhn active positions
| Companies | Position | Start |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Chairman | 2015-05-16 |
SpinChip Diagnostics AS
SpinChip Diagnostics AS Medical SpecialtiesHealth Technology Operates as a diagnostic company that provides immunoassay diagnostics test services | Director/Board Member | - |
Svanhild og Arne Musts fond for medisinsk forskning
Svanhild og Arne Musts fond for medisinsk forskning Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 2011-12-31 |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Director/Board Member | 2017-04-30 |
Former positions of Hans Peter Bøhn
| Companies | Position | End |
|---|---|---|
Fondsfinans AS
Fondsfinans AS Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
PCI Biotech Holding ASA
PCI Biotech Holding ASA BiotechnologyHealth Technology Develops photochemical drug delivery technology for use in therapeutic treatment | Health Technology |
Svanhild og Arne Musts fond for medisinsk forskning
Svanhild og Arne Musts fond for medisinsk forskning Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Fondsfinans AS
Fondsfinans AS Investment Banks/BrokersFinance Provides brokerage services | Finance |
SpinChip Diagnostics AS
SpinChip Diagnostics AS Medical SpecialtiesHealth Technology Operates as a diagnostic company that provides immunoassay diagnostics test services | Health Technology |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Health Technology |
- Stock Market
- Insiders
- Hans Peter Bøhn
















